跳至主要内容
临床试验/CTRI/2011/07/001874
CTRI/2011/07/001874招募中3 期

Evaluation of a progesterone vaginal ring as a new contraceptive option in India - PVR study

Indian Council of Medical Research0 个研究点目标入组 1,600 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
1,600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Able to provide informed consent
  • 2.Age 20 to 35 years (inclusive)
  • 3.Delivered a healthy singleton infant 6 to 9 weeks prior to study enrollment
  • 4.Has at least one (1) living child and is exclusively breastfeeding the new infant
  • (no supplementary feedings)
  • 5.The new breast fed infant?s weight is more than -2SD as per WHO weight for age standards
  • 6.Experienced a normal post partum period
  • 7.Is in good health as confirmed by medical history, physical examination (including vital signs), pelvic/breast examination, and results of laboratory tests at the screening visit
  • 8.Willing to continue breastfeeding at least for one year
  • 9.Has or expects to have regular exposure to the risk of pregnancy
  • 10.Not currently using any method of contraception including barrier or conventional (abstinence, withdrawal, safe period) methods
  • 11.Willing to be counseled on all methods of contraception & choose one study method (PVR/IUD)
  • 12.Willing and able to follow study procedures & come to study center for study visits as described in the protocol
  • 13.Expects to continue living in an area accessible to the study center for the duration of the study

排除标准

  • 1.Are pregnant or are suspected of being pregnant
  • 2.Giving supplementary feeds to the new infant
  • 3.Clinically relevant genital prolapse
  • 4.Had postpartum endometritis or puerperal sepsis
  • 5.Had pelvic inflammatory disease or salpingitis since delivery
  • 6.Are hypersensitive to hormonal preparations or silicone rubber
  • 7.History of generalized urticaria
  • 8.Any chronic condition requiring continuous or regular use of medication
  • 9.Known or suspected diabetes or thyroid disease
  • 10.History of thrombophlebitis or thromboembolism
  • 11.Has a cerebrovascular disorder or coronary artery disease
  • 12.History of and/or current incapacitating migraine
  • 13.Confirmed hypertension or a history of severe pre-eclampsia
  • 14.Neurovascular lesion of the eye or serious visual disturbance at screening
  • 15.History of and/or current depression
  • 16.History of epilepsy or convulsive disorder
  • 17.Known or suspected hepatic adenomas or carcinomas
  • 18.Had an ectopic pregnancy
  • 19.Untreated acute cervicitis or vaginitis
  • 20.Has vaginal bleeding not attributable to menses
  • 21.Current Pap smear suggestive of high-grade pre-cancerous lesion(s), including HGSIL, CIN I and moderate or severe dysplasia
  • 22.Known or suspected uterine or cervical malignancy
  • 23. Known or suspected carcinoma of the breast
  • 24.Has any other known or suspected neoplasia
  • 25.Not cohabiting (not exposed to risk of pregnancy)
  • 26.History of hepatitis or pregnancy-related jaundice
  • 27.History of chronic constipation (for women who choose PVR only)
  • 28.Use of chronic medications, Rifampicin, Griseofluvin, barbiturates, phenytoin, ketoconozole, butazoliden
  • 29.Hemoglobin less than 8 g/dl (colorimeter method for cynmeth Hemoglobin )
  • 30.Urine for albumin, sugar and microscopic examination indicates abnormal results
  • 31.Blood Pressure- systolic more than 130 mm Hg and/or diastolic more than 85 mm Hg

研究者

相似试验